Your browser doesn't support javascript.
loading
Performance of capecitabine in novel combination therapies in colorectal cancer.
Pouya, Fahima Danesh; Rasmi, Yousef; Camci, Irem Yalim; Tutar, Yusuf; Nemati, Mohadeseh.
Affiliation
  • Pouya FD; Department of Biochemistry, School of Medicine, Urmia University of Medical Sciences, Urmia, Iran.
  • Rasmi Y; Department of Biochemistry, School of Medicine, Urmia University of Medical Sciences, Urmia, Iran.
  • Camci IY; Cellular and Molecular Research Center, Urmia University of Medical Sciences, Urmia, Iran.
  • Tutar Y; Department of Molecular Biology and Genetics, Faculty of Science, Gebze Technical University, Kocaeli, Turkey.
  • Nemati M; Division of Biochemistry, Department of Basic Pharmaceutical Sciences, Hamidiye Faculty of Pharmacy, University of Health Sciences, Turkey Istanbul.
J Chemother ; 33(6): 375-389, 2021 Oct.
Article in En | MEDLINE | ID: mdl-34019782

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Colorectal Neoplasms / Antineoplastic Combined Chemotherapy Protocols / Capecitabine Limits: Humans Language: En Journal: J Chemother Journal subject: ANTINEOPLASICOS / TERAPIA POR MEDICAMENTOS Year: 2021 Document type: Article Affiliation country: Iran Country of publication: United kingdom

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Colorectal Neoplasms / Antineoplastic Combined Chemotherapy Protocols / Capecitabine Limits: Humans Language: En Journal: J Chemother Journal subject: ANTINEOPLASICOS / TERAPIA POR MEDICAMENTOS Year: 2021 Document type: Article Affiliation country: Iran Country of publication: United kingdom